SOLIGENIX, INC. Increase Decrease In Operating Lease Liability
SOLIGENIX, INC. (SNGX) reported Increase Decrease In Operating Lease Liability of -$55.55 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- SOLIGENIX, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$28.07K.
- SOLIGENIX, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$27.48K.
- SOLIGENIX, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$26.91K.
- SOLIGENIX, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$26.35K.
- SOLIGENIX, INC. increase decrease in operating lease liability for fiscal 2025 was -$114.32K.
- SOLIGENIX, INC. increase decrease in operating lease liability for fiscal 2024 was -$121.77K.
- SOLIGENIX, INC. increase decrease in operating lease liability for fiscal 2023 was -$108.95K.
- SOLIGENIX, INC. increase decrease in operating lease liability for fiscal 2022 was -$111.12K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$28.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$55.55K 10-Q · filed 2026-08-07 | -$82.47K derived: sum of 3 quarters · filed 2026-08-07 | -$108.81K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$27.48K 10-Q · filed 2026-05-08 | -$54.40K derived: sum of 2 quarters · filed 2026-05-08 | -$80.74K derived: sum of 3 quarters · filed 2026-05-08 | -$109.07K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$26.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$53.26K derived: sum of 2 quarters · filed 2026-03-31 | -$81.58K derived: sum of 3 quarters · filed 2026-08-07 | -$114.32K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$26.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$54.67K derived: sum of 2 quarters · filed 2026-08-07 | -$87.41K 10-Q · filed 2025-11-07 | -$119.21K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$28.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$61.06K 10-Q · filed 2026-08-07 | -$92.86K derived: sum of 3 quarters · filed 2026-08-07 | -$123.48K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$32.74K 10-Q · filed 2026-05-08 | -$64.53K derived: sum of 2 quarters · filed 2026-05-08 | -$95.16K derived: sum of 3 quarters · filed 2026-05-08 | -$125.14K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$31.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$62.42K derived: sum of 2 quarters · filed 2026-03-31 | -$92.41K derived: sum of 3 quarters · filed 2026-03-31 | -$121.77K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$30.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$60.61K derived: sum of 2 quarters · filed 2025-11-07 | -$89.97K 10-Q · filed 2025-11-07 | -$118.46K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$29.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$59.34K 10-Q · filed 2025-08-14 | -$87.83K derived: sum of 3 quarters · filed 2025-08-14 | -$115.22K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$29.36K 10-Q · filed 2025-05-09 | -$57.85K derived: sum of 2 quarters · filed 2025-05-09 | -$85.24K derived: sum of 3 quarters · filed 2025-05-09 | -$112.05K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$28.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$55.88K derived: sum of 2 quarters · filed 2025-03-21 | -$82.69K derived: sum of 3 quarters · filed 2025-03-21 | -$108.95K 10-K · filed 2025-03-21 |
| 2023-09-30 | -$27.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$54.20K derived: sum of 2 quarters · filed 2024-11-08 | -$80.46K 10-Q · filed 2024-11-08 | -$106.17K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$26.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$53.07K 10-Q · filed 2024-08-09 | -$78.78K derived: sum of 3 quarters · filed 2024-08-09 | -$103.95K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$26.26K 10-Q · filed 2024-05-10 | -$51.96K derived: sum of 2 quarters · filed 2024-05-10 | -$77.13K derived: sum of 3 quarters · filed 2024-05-10 | -$106.46K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$25.71K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$50.88K derived: sum of 2 quarters · filed 2024-03-15 | -$80.20K derived: sum of 3 quarters · filed 2024-03-15 | -$111.12K 10-K · filed 2024-03-15 |
| 2022-09-30 | -$25.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$54.49K derived: sum of 2 quarters · filed 2023-11-13 | -$85.42K 10-Q · filed 2023-11-13 | -$115.58K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$29.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$60.24K 10-Q · filed 2023-08-21 | -$90.41K derived: sum of 3 quarters · filed 2023-08-21 | -$119.84K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | -$30.92K 10-Q · filed 2023-05-15 | -$61.09K derived: sum of 2 quarters · filed 2023-05-15 | -$90.51K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$30.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$59.59K derived: sum of 2 quarters · filed 2023-03-31 | -$116.29K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$29.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$86.12K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$56.70K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |